Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Account Payables (2016 - 2017)

Historic Change in Account Payables for Macrogenics (MGNX) over the last 6 years, with Q2 2017 value amounting to $197000.0.

  • Macrogenics' Change in Account Payables rose 49696.97% to $197000.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $561000.0, marking a year-over-year increase of 17991.45%. This contributed to the annual value of -$1.5 million for FY2024, which is 21943.79% down from last year.
  • As of Q2 2017, Macrogenics' Change in Account Payables stood at $197000.0, which was up 49696.97% from -$2.2 million recorded in Q1 2017.
  • Over the past 5 years, Macrogenics' Change in Account Payables peaked at $2.4 million during Q4 2016, and registered a low of -$2.7 million during Q4 2014.
  • Moreover, its 5-year median value for Change in Account Payables was -$96000.0 (2015), whereas its average is -$112611.1.
  • Within the past 5 years, the most significant YoY rise in Macrogenics' Change in Account Payables was 49696.97% (2017), while the steepest drop was 47293.81% (2017).
  • Over the past 5 years, Macrogenics' Change in Account Payables (Quarter) stood at $1.4 million in 2013, then plummeted by 298.32% to -$2.7 million in 2014, then soared by 61.93% to -$1.0 million in 2015, then surged by 328.5% to $2.4 million in 2016, then crashed by 91.67% to $197000.0 in 2017.
  • Its last three reported values are $197000.0 in Q2 2017, -$2.2 million for Q1 2017, and $2.4 million during Q4 2016.